Haloprogin

From Self-sufficiency
Revision as of 16:09, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Haloprogin
File:Haloprogin.png
Systematic (IUPAC) name
1,2,4-trichloro-5-[(3-iodoprop-2-yn-1-yl)oxy]benzene
Clinical data
Routes of
administration
Topical
Legal status
Legal status
  • Not available in U.S.
Identifiers
CAS Number 777-11-7
ATC code D01AE11 (WHO)
PubChem CID 3561
DrugBank APRD01011
Chemical data
Formula C9H4Cl3IO
Molar mass 361.39[[Script error: No such module "String".]]
Physical data
Melting point 113.5 °C (236.3 °F)
  (verify)
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Haloprogin is an antifungal drug used to treat athlete's foot and other fungal infections. It is marketed in creams under the trade names Halotex, Mycanden, Mycilan, and Polik.

Action

Haloprogin was previously used in 1% topical creams as an antifungal agent. It was marketed over the counter primarily to treat tinea infections of the skin. The mechanism of action is unknown.[1]

Haloprogin had a high incidence of side effects including: irritation, burning, vesiculation (blisters), scaling, and itching. It has since been discontinued due to the emergence of more modern antifungals with fewer side effects.[2]

References

  1. "Haloprogin". Drugs@FDA. Food and Drug Administration. Retrieved 2007-02-17. 
  2. "Haloprogin". DrugBank. University of Alberta. Nov 06, 2006. Retrieved 2007-02-17.  Check date values in: |date= (help)